ORPEA

Board/Management Information • Dec 14, 2016

BOARD OF DIRECTORS STRENGTHENED AND ITS GENDER BALANCE ENHANCED BY THE APPOINTMENT OF TWO NEW INDEPENDENT MEMBERS :

LAURE BAUME AND BRIGITTE LANTZ

Puteaux, 14 December 2016

The ORPEA group, one of the leading European providers of long- and medium-term care (nursing homes, post-acute and rehabilitation hospitals psychiatric hospitals, and homecare services), has announced that today's Ordinary General Meeting approved the appointment of Laure Baume and Brigitte Lantz as new directors.

Laure Baume is Aéroports de Paris' Deputy Chief Executive Officer and Head of its Customer division, as well as a member of its Executive Committee.

A graduate of HEC Paris business school, she began her career at Kraft Foods International, where she held several positions in France and abroad. She then joined Club Méditerranée's general management committee as Head of the Group's Europe-Africa New Markets BU and Head of Strategic Marketing.

Brigitte Lantz is a doctor specialising in nephrology. She graduated from the Paris Faculty of Medicine, is a practising hospital physician at Necker hospital and holds a DEA postgraduate degree in endocrinology.

Between 2002 and 2012, Brigitte advised several health ministers on various fields, including chronic conditions (Alzheimer's disease, Parkinson's disease, chronic kidney disease, diabetes, etc.), disabilities and dependency, the elderly and severe head injuries.

These two appointments broaden the range of medical and international expansion skills and expertise held by members of ORPEA's Board of Directors as the new directors possess vast experience.

After reviewing the candidates' status, ORPEA's Appointments and Compensation Committee determined based on the criteria of the AFEP-MEDEF Code that both these new directors can be considered as independent under this Code.

These appointments have strengthened the Group's governance, and its now highly diverse Board of Directors has 12 members, 66% of whom are independent directors, with four different nationalities represented.

Next press release: revenue for 2016 full-year 8 February 2016 before the market opens

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is a European leader in integrated Long-Term Care and Post-Acute Care, with a network of 733 healthcare facilities, with 74,272 beds (9,041 of them under refurbishment or construction), including:

• 32,688 beds in France at 352 facilities (2,993 beds under refurbishment or construction);
• 41,584 beds in the rest of Europe (Germany, Austria, Belgium, Spain, Italy, Czech Republic, Poland and Switzerland) at 381 facilities (6,048 beds under refurbishment or construction).

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and member of SBF 120, STOXX Europe 600, MSCI Small Cap Europe and CAC Mid 60 indices.

Investor Relations :

Yves Le Masne	Steve Grobet	NewCap
CEO	Investor Relations Officer	Dusan Oresansky / Nicolas Merigeau
	Tel: +33 (0)1 47 75 74 66	Tel: +33 (0)1 44 71 94 94
	s.grobet@orpea.net	orpea@newcap.eu

ORPEA Investor and Media Relations: